Company & Sponsor Intelligence

Mclean Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting2

Completed7

Countries1

Therapeutic footprint

alzheimersanxietybipolar_disorderdepressioneating_disorders

Indexed studies

NCT01557946Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
depression · United StatesPHASE4

NCT04430517Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
alzheimers · United StatesEARLY_PHASE1

NCT03712267Electronic Media and Its Application in Psychotherapy
depression · United StatesNA

NCT04125589Decision Making, Daily Experiences, and Brain Activity in Young Adult Women
eating_disorders · United StatesNA

NCT06107764Cerebellar Modulation of Cognition in Psychosis
bipolar_disorder · United StatesNA

NCT00183755Understanding Brain Reward Responses in Individuals With Major Depressive Disorder
depression · United StatesCOMPLETED

NCT01390389Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression
depression · United StatesNA

NCT05665491Role of Parent Interpretation Bias in the Transmission of Anxiety to Children
anxiety · United StatesNA

NCT04556097Implementation of the Care Ecosystem Training Model for Individuals With Dementia in a High-risk, Integrated Care Management
alzheimers · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →